JHEP Rep. 2021 Aug 12;3(5):100351. doi: 10.1016/j.jhepr.2021.100351. eCollection 2021 Oct.
Excellent outcomes with liver transplantation in hepatopulmonary syndrome across pre-transplant PaO.
JHEP reports : innovation in hepatology
Zakiyah Kadry, Eric Schaefer, Karen Krok, Alison Faust, Jonathan Gibson Stine, Ian Roy Schreibman, Dmitri Bezinover, Thomas Roberts Riley
Affiliations
Affiliations
- Division of Transplantation, Department of Surgery, Penn State College of Medicine, Hershey, PA, USA.
- Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
- Division of Gastroenterology and Hepatology, Department of Medicine, Penn State College of Medicine, Hershey, PA, USA.
- Department of Anesthesiology, Penn State College of Medicine, Hershey, PA, USA.
PMID: 34604726
PMCID: PMC8473556 DOI: 10.1016/j.jhepr.2021.100351
Abstract
BACKGROUND & AIMS: Significantly worse survival has been reported in patients with hepatopulmonary syndrome (HPS) and partial pressure of arterial oxygen (PaO
METHODS: A retrospective analysis of 1,152 HPS candidates listed with an approved HPS model for end-stage liver disease (MELD) exception was performed. A Fine and Gray competing risks model was utilised to evaluate pre-transplant outcomes for PaO
RESULTS: Patients with a PaO
CONCLUSIONS: Patients with a PaO
LAY SUMMARY: A total of 1,152 patients with hepatopulmonary syndrome listed for liver transplant were analysed. Patients with a low PaO
© 2021 The Authors.
Keywords: CIF, cumulative incidence function; ECMO, extracorporeal membrane oxygenation; HPS, hepatopulmonary syndrome; HR, hazard ratio; Hepatopulmonary syndrome; Hypoxia; Liver transplantation; MELD, model for end-stage liver disease; NASH, non-alcoholic steatohepatitis; OPTN, Organ Procurement and Transplant Network; POPH, portopulmonary hypertension; PaO2, partial pressure of arterial oxygen; STAR, Standard Transplant Analysis and Research; UNOS, United Network for Organ Sharing
Conflict of interest statement
The authors have no conflicts of interest or financial disclosures to make. Please refer to the accompanying ICMJE disclosure forms for further details.
References
- J Hepatobiliary Pancreat Sci. 2019 Jul;26(7):292-299 - PubMed
- Pediatr Transplant. 2012 Nov;16(7):E281-5 - PubMed
- Liver Transpl. 2015 Nov;21(11):1355-64 - PubMed
- Gastroenterology. 2006 Jul;131(1):69-75 - PubMed
- Hepatology. 2005 May;41(5):1122-9 - PubMed
- Stat Med. 2007 Oct 30;26(24):4505-19 - PubMed
- Liver Transpl. 2014 Sep;20(9):1141-4 - PubMed
- Gastroenterology. 2014 May;146(5):1256-65.e1 - PubMed
- Eur Respir J. 2019 Jan 31;53(2): - PubMed
- Hepatology. 2013 Jun;57(6):2427-35 - PubMed
- Hepatol Res. 2018 Mar;48(4):225-232 - PubMed
- Gastroenterology. 2003 Oct;125(4):1042-52 - PubMed
- Gastroenterology. 2008 Oct;135(4):1168-75 - PubMed
- Pediatr Transplant. 2017 Nov;21(7): - PubMed
- World J Gastroenterol. 2018 Mar 28;24(12):1285-1298 - PubMed
- Liver Transpl. 2008 Jul;14(7):966-70 - PubMed
- CMAJ. 2018 Feb 26;190(8):E223 - PubMed
- Int J Artif Organs. 2021 Jan 21;:391398821989067 - PubMed
- Am J Transplant. 2010 Feb;10(2):354-63 - PubMed
- Transplantation. 2003 May 15;75(9):1482-9; discussion 1446-7 - PubMed
- Am J Transplant. 2015 Apr;15(4):903-13 - PubMed
- Clin Gastroenterol Hepatol. 2007 Jun;5(6):749-54 - PubMed
- Transplantation. 2016 Jul;100(7):1440-52 - PubMed
- Clin Chest Med. 2017 Dec;38(4):785-795 - PubMed
- Int J Artif Organs. 2015 Mar;38(3):170-2 - PubMed
- Transplantation. 1993 Jan;55(1):212-4 - PubMed
- Liver Transpl. 2014 Feb;20(2):182-90 - PubMed
- Liver Transpl. 2006 Dec;12(12 Suppl 3):S105-7 - PubMed
- Crit Care. 2011;15(5):R234 - PubMed
- Am J Transplant. 2008 May;8(5):954-64 - PubMed
- Respir Med. 2013 Jul;107(7):1030-6 - PubMed
- Echocardiography. 2006 Apr;23(4):271-8 - PubMed
Publication Types